Time toxicity associated with early phase clinical trial participation

Article Properties
Cite
Nindra, U., et al. “Time Toxicity Associated With Early Phase Clinical Trial Participation”. ESMO Open, vol. 8, no. 6, 2023, p. 102046, https://doi.org/10.1016/j.esmoop.2023.102046.
Nindra, U., Shivasabesan, G., Childs, S., Yoon, R., Haider, S., Hong, M., Cooper, A., Roohullah, A., Wilkinson, K., Pal, A., & Chua, W. (2023). Time toxicity associated with early phase clinical trial participation. ESMO Open, 8(6), 102046. https://doi.org/10.1016/j.esmoop.2023.102046
Nindra, U., G. Shivasabesan, S. Childs, R. Yoon, S. Haider, M. Hong, A. Cooper, et al. “Time Toxicity Associated With Early Phase Clinical Trial Participation”. ESMO Open 8, no. 6 (2023): 102046. https://doi.org/10.1016/j.esmoop.2023.102046.
Nindra U, Shivasabesan G, Childs S, Yoon R, Haider S, Hong M, et al. Time toxicity associated with early phase clinical trial participation. ESMO Open. 2023;8(6):102046.
Refrences
Title Journal Journal Categories Citations Publication Date
Impact of travel distance on outcomes for clinical trial patients: the Kinghorn Cancer Centre experience

 Internal Medicine Journal
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 1 2023
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 Annals of Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 25 2023
Time toxicity in early phase clinical trials (EP-CTs) 2022
The time toxicity of cancer treatment 2022
Does Enrollment in Cancer Trials Improve Survival? Journal of the American College of Surgeons
  • Medicine: Medicine (General)
  • Medicine: Surgery
  • Medicine: Medicine (General)
 76 2013
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)4
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
Medicine: Internal medicine1
The category Medicine: Medicine (General) 4 is the most frequently represented among the references in this article. It primarily includes studies from Critical Reviews in Oncology/Hematology and Internal Medicine Journal. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Reporting time toxicity in prospective cancer clinical trials: A scoping review Supportive Care in Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General): Medical technology
  • Medicine: Internal medicine: Special situations and conditions: Sports medicine
  • Medicine: Medicine (General)
 2024
Survival outcomes in older adults undergoing early phase clinical trials Journal of Geriatric Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Special situations and conditions: Geriatrics
  • Medicine: Medicine (General)
 2024
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens2
Medicine: Medicine (General)2
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine: Special situations and conditions: Sports medicine1
Medicine: Internal medicine: Special situations and conditions: Geriatrics1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 2 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Reporting time toxicity in prospective cancer clinical trials: A scoping review and was published in 2024. The most recent citation comes from a 2024 study titled Reporting time toxicity in prospective cancer clinical trials: A scoping review. This article reached its peak citation in 2024, with 2 citations. It has been cited in 2 different journals. Among related journals, the Supportive Care in Cancer cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year